S

eeking to provide more transparency into medical industry practices, the Ontario government last week unveiled draft regulations that would require drug makers to disclose payments and gifts to prescribers, an effort that industry critics suggest could become a model for all of Canada.

The proposal is largely similar to a U.S. law, called the Sunshine Act, that has a $10 reporting threshold, but the Ontario draft goes a few steps further. Companies would have to disclose payments not only to physicians, but to other regulated health professionals, such as nurses and pharmacists. And payments to patient advocacy groups and professional medical societies would also have to be reported.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy